IRIS PubliCatt

Cauda, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.479
NA - Nord America 10.392
AS - Asia 2.581
SA - Sud America 45
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 16
Totale 25.579
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.297
DE - Germania 4.287
SE - Svezia 2.065
CN - Cina 1.977
IT - Italia 1.167
PL - Polonia 1.128
UA - Ucraina 1.117
FR - Francia 907
IE - Irlanda 705
GB - Regno Unito 428
FI - Finlandia 279
TR - Turchia 242
IN - India 217
BE - Belgio 164
RU - Federazione Russa 56
IR - Iran 51
CA - Canada 48
AT - Austria 43
JP - Giappone 38
NL - Olanda 36
MX - Messico 29
CI - Costa d'Avorio 22
EU - Europa 22
BR - Brasile 21
AU - Australia 14
CH - Svizzera 14
BZ - Belize 13
ES - Italia 12
VN - Vietnam 12
SG - Singapore 10
CO - Colombia 9
EG - Egitto 8
GR - Grecia 8
PT - Portogallo 7
RO - Romania 7
AR - Argentina 6
MY - Malesia 6
AL - Albania 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
HU - Ungheria 5
PH - Filippine 5
VA - Santa Sede (Città del Vaticano) 5
HK - Hong Kong 4
NG - Nigeria 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BY - Bielorussia 3
CL - Cile 3
ID - Indonesia 3
LT - Lituania 3
PA - Panama 3
BN - Brunei Darussalam 2
EC - Ecuador 2
EE - Estonia 2
HR - Croazia 2
KE - Kenya 2
KR - Corea 2
LU - Lussemburgo 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
ZA - Sudafrica 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BO - Bolivia 1
CY - Cipro 1
ET - Etiopia 1
GL - Groenlandia 1
IQ - Iraq 1
IS - Islanda 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
PR - Porto Rico 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
VE - Venezuela 1
Totale 25.579
Salva come PNG Salva come JPEG
Città #
Chandler 2.407
Jacksonville 748
Dublin 696
Warsaw 582
San Mateo 566
Kraków 542
Hangzhou 480
Nanjing 430
Ashburn 396
Ann Arbor 394
Dearborn 351
Wilmington 340
Houston 310
Woodbridge 308
Nürnberg 294
Izmir 226
Boston 218
Redmond 185
Lawrence 183
Fairfield 181
Cattolica 179
Nanchang 172
Beijing 164
Brussels 158
Seattle 156
Marseille 151
Princeton 151
Redwood City 135
Lancaster 120
Milan 119
Bremen 109
Rome 103
Shenyang 100
Kunming 89
Munich 85
Boardman 82
Hebei 73
Mountain View 73
Norwalk 71
University Park 63
Cambridge 62
Tianjin 61
Chicago 59
Fremont 59
Changsha 54
Leawood 53
Jiaxing 48
Augusta 44
Zhengzhou 44
Vienna 39
Guangzhou 37
Jinan 37
Shanghai 37
New York 35
Verona 35
Helsinki 32
Simi Valley 32
San Jose 31
Hefei 25
Philadelphia 25
London 23
Abidjan 22
Los Angeles 22
Kish 21
Buffalo 20
Falls Church 20
Andover 19
Edinburgh 19
Ottawa 19
Changchun 17
Lanzhou 17
Auburn Hills 15
Detroit 15
Ningbo 15
Belize City 13
Boydton 13
Fuzhou 13
Toronto 13
Amsterdam 12
Las Vegas 12
Phoenix 12
Cuauhtémoc 11
Tokyo 11
Costa Mesa 10
São Paulo 10
Taizhou 9
Viterbo 9
Chengdu 8
Indiana 8
Phoenixville 8
Tavagnacco 8
Clearwater 7
Genoa 7
Montréal 7
Mumbai 7
Quattro Castella 7
San Diego 7
Ardabil 6
Bern 6
Chongqing 6
Totale 13.543
Salva come PNG Salva come JPEG
Nome #
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 331
New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years 321
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR. 308
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 305
Factors associated with mortality in bacteremic patients with hematologic malignancies. 294
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 290
Factors associated with mortality in bacteremic patients with haematologic malignancies 289
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 271
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 251
Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients 210
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 208
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 197
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 191
La pandemia di COVID-19: un limite o una frontiera per la Legge 24/2017? 170
Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility 164
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 162
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 160
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 160
Factors associated with mortality in bacteremic patients with hematologic malignancies. 158
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 151
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 150
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 149
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 143
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 142
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 141
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 139
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 136
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 136
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 135
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 131
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 130
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 129
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 128
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 128
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 128
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 128
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 125
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients 118
Variability of raltegravir plasma levels in the clinical setting 118
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 117
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure 117
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 116
Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV infected subjects 116
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 116
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 115
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies 114
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection 113
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 112
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis 111
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. 110
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 110
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome 109
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 106
Initial antifungal strategy does not correlate with mortality in patients with candidemia 105
Attitudes and practices of dentists treating HIV patients in HAART era. 104
Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy 104
The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study 104
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial 104
Testimonianze dalle periferie del mondo. Sei anni di Charity Work Program Quaderni del CeSI Edizione Vita e Pensiero . 102
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. 101
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 100
Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy 99
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators 98
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients, a systematic review and meta-analysis 98
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 98
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 97
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction 97
Cardiovascular risk factors and carotid intima-media thickness are associated with low cognitive performance in HIV-infected patients 97
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates 97
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 97
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 96
Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection 95
Predictors of successful genotype-guided antiretroviral therapy in treatment-experienced individuals over calendar year: a cohort study 95
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 95
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 95
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 95
Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS 95
Bloodstream infections caused by extended -spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome 93
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study 93
HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy 91
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 91
HIV-infected patients show impaired cellular immune response to influenza vaccination, compared to healthy subjects 91
Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis 91
Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure. 90
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. 90
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop 90
Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections 90
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 90
Cognitive reserve and neuropsychological functioning in older HIV-infected people 90
Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model? 89
Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy. 88
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients 88
Impact of antibiotic stewardship on perioperative antimicrobial prophylaxis 88
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 88
Are mutations in HIV type-1 reverse transcriptase 245 codon predictive of abacavir hypersensitivity reaction? 87
Virological suppression reduces clinical progression in patients with multiclass-resistant HIV type 1 87
How could we reduce antibiotic use in critically ill patients? 87
A new, striking morphological alteration of P-glycoprotein expression in NK cells from AIDS patients 87
Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: two years experience in routine clinical practice 87
Effect of aging and human immunodeficiency virus infection on cognitive abilities 87
Totale 13.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.941
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.941
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.595 0 0 115 233 415 335 382 111 114 257 369 264
2019/20204.006 744 238 264 263 335 418 355 166 287 250 344 342
2020/20212.708 214 290 70 267 329 173 284 61 407 124 428 61
2021/20223.147 257 256 85 240 133 108 70 516 126 222 481 653
2022/20236.666 833 941 538 960 514 740 291 534 858 135 227 95
2023/20241.224 152 1.014 58 0 0 0 0 0 0 0 0 0
Totale 25.939